Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Other financing activities (2016 - 2021)

Vycor Medical has reported Other financing activities over the past 6 years, most recently at $20839.0 for Q3 2021.

  • Quarterly Other financing activities rose 48.85% to $20839.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $20725.0 through Mar 2022, down 70.39% year-over-year, with the annual reading at $21000.0 for FY2021, 70.0% down from the prior year.
  • Other financing activities was $20839.0 for Q3 2021 at Vycor Medical, up from -$114.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $86754.0 in Q2 2018 and troughed at -$114.0 in Q2 2021.
  • The 4-year median for Other financing activities is $17419.5 (2020), against an average of $20114.8.
  • The largest YoY upside for Other financing activities was 10404.2% in 2017 against a maximum downside of 101.69% in 2017.
  • A 4-year view of Other financing activities shows it stood at -$1.0 in 2017, then skyrocketed by 52900.0% to $528.0 in 2018, then skyrocketed by 2551.52% to $14000.0 in 2020, then soared by 48.85% to $20839.0 in 2021.
  • Per Business Quant, the three most recent readings for VYCO's Other financing activities are $20839.0 (Q3 2021), -$114.0 (Q2 2021), and $21000.0 (Q1 2021).